Trademark: 87043574
Status Date
Monday, December 17, 2018
Filing Date
Thursday, May 19, 2016
Abandoned Date
Friday, November 23, 2018
5 Radiopharmaceutical imaging and detection agents developed using monoclonal antibodies for diagnosing and monitoring cancer; Diagnostic kits consisting primarily of monoclonal antibodies, and reagents for use in disease testing; Therapeutic pharmaceuticals developed using monoclonal antibodies for the treatment of cancer and other malignancies
Dec 17, 2018
Abandonment Notice E-Mailed - Failure To Respond
Dec 17, 2018
Abandonment - Failure To Respond Or Late Response
May 21, 2018
Notification Of Non-Final Action E-Mailed
May 21, 2018
Non-Final Action E-Mailed
May 21, 2018
Non-Final Action Written
Apr 27, 2018
Teas/Email Correspondence Entered
Apr 26, 2018
Correspondence Received In Law Office
Apr 26, 2018
Teas Response To Office Action Received
Nov 2, 2017
Notification Of Non-Final Action E-Mailed
Nov 2, 2017
Non-Final Action E-Mailed
Nov 2, 2017
Non-Final Action Written
Oct 16, 2017
Previous Allowance Count Withdrawn
Apr 14, 2017
Withdrawn From Pub - Managing Attorney Request
Mar 27, 2017
Approved For Pub - Principal Register
Mar 11, 2017
Teas/Email Correspondence Entered
Mar 9, 2017
Correspondence Received In Law Office
Mar 9, 2017
Teas Response To Office Action Received
Sep 9, 2016
Notification Of Non-Final Action E-Mailed
Sep 9, 2016
Non-Final Action E-Mailed
Sep 9, 2016
Non-Final Action Written
Sep 3, 2016
Assigned To Examiner
May 25, 2016
New Application Office Supplied Data Entered In Tram
May 23, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
